| Courtney K Bell, APRN | |
|
18 Church St, Arlington, VT 05250-4457 | |
| (802) 375-6556 | |
| Not Available |
| Full Name | Courtney K Bell |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 18 Church St, Arlington, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922664549 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 101.0134559 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southwestern Vermont Medical Center | Bennington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Battenkill Valley Health Center Inc | 2769612548 | 6 |
| Battenkill Valley Health Center Inc | 2769612548 | 6 |
News Archive
The Senate's health overhaul plan would cover 33 million more people but fail to curb rising health costs, could threaten some Medicare patients' access to care, and may sink profits for one-fifth of hospitals and nursing homes, according to news accounts of an HHS report released Friday afternoon.
Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that results of a large, European single-center experience of the treatment of uveal melanoma patients with hepatic metastases with the Delcath Hepatic CHEMOSAT® Delivery System, were highlighted in an on-line abstract at the American Society of Clinical Oncology Annual Meeting 2015.
Johns Hopkins and Yale scientists have found that melanoma cells use a cloaking protein to hide from immune cells poised to attack the cancer. Nearly 40 percent of their sampling of melanoma tissues contained the B7-H1 protein, also called PD-L1, and scientists say it could be used as a target for new therapies.
Many studies have examined motor impairments using voxel-based lesion symptom mapping (VLSM), but few are reported regarding the corresponding relationship between cerebral cortex injury and lower limb motor impairment analyzed using this technique.
› Verified 9 days ago
| Entity Name | Planned Parenthood Mohawk Hudson, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376618843 PECOS PAC ID: 5092012492 Enrollment ID: O20160330001740 |
News Archive
The Senate's health overhaul plan would cover 33 million more people but fail to curb rising health costs, could threaten some Medicare patients' access to care, and may sink profits for one-fifth of hospitals and nursing homes, according to news accounts of an HHS report released Friday afternoon.
Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that results of a large, European single-center experience of the treatment of uveal melanoma patients with hepatic metastases with the Delcath Hepatic CHEMOSAT® Delivery System, were highlighted in an on-line abstract at the American Society of Clinical Oncology Annual Meeting 2015.
Johns Hopkins and Yale scientists have found that melanoma cells use a cloaking protein to hide from immune cells poised to attack the cancer. Nearly 40 percent of their sampling of melanoma tissues contained the B7-H1 protein, also called PD-L1, and scientists say it could be used as a target for new therapies.
Many studies have examined motor impairments using voxel-based lesion symptom mapping (VLSM), but few are reported regarding the corresponding relationship between cerebral cortex injury and lower limb motor impairment analyzed using this technique.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Courtney K Bell, APRN Po Box 61, Arlington, VT 05250-0061 Ph: (802) 375-6566 | Courtney K Bell, APRN 18 Church St, Arlington, VT 05250-4457 Ph: (802) 375-6556 |
News Archive
The Senate's health overhaul plan would cover 33 million more people but fail to curb rising health costs, could threaten some Medicare patients' access to care, and may sink profits for one-fifth of hospitals and nursing homes, according to news accounts of an HHS report released Friday afternoon.
Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that results of a large, European single-center experience of the treatment of uveal melanoma patients with hepatic metastases with the Delcath Hepatic CHEMOSAT® Delivery System, were highlighted in an on-line abstract at the American Society of Clinical Oncology Annual Meeting 2015.
Johns Hopkins and Yale scientists have found that melanoma cells use a cloaking protein to hide from immune cells poised to attack the cancer. Nearly 40 percent of their sampling of melanoma tissues contained the B7-H1 protein, also called PD-L1, and scientists say it could be used as a target for new therapies.
Many studies have examined motor impairments using voxel-based lesion symptom mapping (VLSM), but few are reported regarding the corresponding relationship between cerebral cortex injury and lower limb motor impairment analyzed using this technique.
› Verified 9 days ago
Ms. Arlene Ruth Law, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6634 Vt Route 313 W, Arlington, VT 05250 Phone: 518-701-1697 | |
Melissa J Prouty, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9 Church St, Arlington, VT 05250 Phone: 802-375-6566 |